Zobrazeno 1 - 10
of 117
pro vyhledávání: '"59"'
Autor:
M. Barbacid
Publikováno v:
European Journal of Cancer. 48:S14-S15
Publikováno v:
European Journal of Cancer. 50:S15
Autor:
Ummugul Uyeturk, Berna Oksuzoglu, Onur Esbah, Kaan Helvaci, U. Yalcintas Arslan, O. Uysal Sonmez, Ahmet Siyar Ekinci, Oznur Bal, Ibrahim Turker, Burcin Budakoglu
Publikováno v:
European Journal of Cancer. 48:S58
Autor:
J.B.A.G. Haanen
Publikováno v:
European Journal of Cancer. 47:S16
Autor:
Franco Aversa, C. Raimondi, Tiziana Zei, Loredana Ruggeri, Andrea Velardi, P. Sodani, R. Jacucci, M F Martelli, Alessandra Carotti, Rita Felicini, A. Trenzi, Paolo Latini, Cynthia Aristei
Publikováno v:
European Journal of Cancer. 32:S12
T cell-depletion of the donor bone marrow prevents GvHD in matched BMT recipients, but this benefit is offset by an increased risk of graft failure and leukemia relapse. One approach 10 improving disease-free survival of TCD transplants recipients is
Autor:
S. Cobelli, M. Tomirotti, Silvia Perrone, N. La Verde, A. Scanni, C. Mantica, Gabriella Farina, M. Dambrosio
Publikováno v:
European Journal of Cancer. 31:S14
To evaluate collateral effects of a TAM prolonged treatment, we analyzed, in a retrospective study, 243 pts, whose mean age was 59.2 years (27-85), all BC treated with radical surgery and adjuvant TAM for more than 2 years, 61/243 in premenopausal (2
Autor:
Harald Kittler, Julia K. Winkler, Holger A. Haenssle, Katharina Sies, Alexander Enk, Philipp Tschandl, Ferdinand Toberer, Christine Fink
Publikováno v:
European Journal of Cancer. 160:180-188
Background Sequential digital dermoscopy (SDD) is applied for early melanoma detection by uncovering dynamic changes of monitored lesions. Convolutional neural networks (CNN) are capable of high diagnostic accuracies similar to trained dermatologists
Autor:
Eric P. van der Stok, Cornelis J. A. Punt, Leonie J. M. Mekenkamp, Cornelis Verhoef, Bastiaan Wiering, Miriam Koopman, Jannemarie A. M. de Ridder, Johannes H. W. de Wilt
Publikováno v:
European Journal of Cancer, 59, 13-21. Elsevier Ltd.
European Journal of Cancer, 59, 13-21
European journal of cancer (Oxford, England, 59, 13-21. Elsevier Limited
European Journal of Cancer, 59, 13. Elsevier Limited
European Journal of Cancer, 59, pp. 13-21
European Journal of Cancer, 59, 13-21
European journal of cancer (Oxford, England, 59, 13-21. Elsevier Limited
European Journal of Cancer, 59, 13. Elsevier Limited
European Journal of Cancer, 59, pp. 13-21
Item does not contain fulltext OBJECTIVE: To evaluate and compare the overall survival (OS) in case-matched patient groups treated either with systemic therapy or surgery for colorectal liver metastases (CRLM). METHODS: Patients with CRLM, without ex
Publikováno v:
European Journal of Cancer. 38:1189-1193
Altogether, 243 female breast cancer patients with localised disease diagnosed between 1991 and 1995 in the Tampere University Hospital area were followed prospectively after primary treatment until the first relapse. In the follow-up period, the ser
Autor:
Eva Ardanaz, Magdalena Bielska-Lasota, Milena Sant, Michel Coleman, Lucia Mangone, Jan Willem Coebergh, Gemma Gatta, Fabio Falcini, Rosario Tumino, Jadwiga Rachtan, Franco Berrino
Publikováno v:
European Journal of Cancer. 37:711-721
EUROCARE is a population-based survival study including data from European Cancer Registries. The present paper analyses survival after a malignant neoplasm of the central nervous system (CNS) in childhood (aged 0--14 years at diagnosis). The databas